150 related articles for article (PubMed ID: 22915782)
21. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
22. Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy.
Zhang Z; Xu J; Zhou T; Yi Y; Li H; Sun H; Huang W; Wang D; Li B; Ying G
Radiat Oncol; 2014 Feb; 9():54. PubMed ID: 24528546
[TBL] [Abstract][Full Text] [Related]
23. Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.
Poltinnikov IM; Fallon K; Xiao Y; Reiff JE; Curran WJ; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):652-8. PubMed ID: 15936541
[TBL] [Abstract][Full Text] [Related]
24. Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity.
Qiao WB; Zhao YH; Zhao YB; Wang RZ
World J Gastroenterol; 2005 May; 11(17):2626-9. PubMed ID: 15849822
[TBL] [Abstract][Full Text] [Related]
25. Incidence and predictors of severe acute esophagitis and subsequent esophageal stricture in patients treated with accelerated hyperfractionated chemoradiation for limited-stage small cell lung cancer.
Grant JD; Shirvani SM; Tang C; Juloori A; Rebueno NC; Allen PK; Chang JY
Pract Radiat Oncol; 2015; 5(4):e383-91. PubMed ID: 25731965
[TBL] [Abstract][Full Text] [Related]
26. A Contralateral Esophagus-Sparing Technique to Limit Severe Esophagitis Associated With Concurrent High-Dose Radiation and Chemotherapy in Patients With Thoracic Malignancies.
Al-Halabi H; Paetzold P; Sharp GC; Olsen C; Willers H
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):803-10. PubMed ID: 26104934
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors for acute esophageal toxicity in thoracic radiotherapy.
Takeda K; Nemoto K; Saito H; Ogawa Y; Takai Y; Yamada S
Tohoku J Exp Med; 2006 Apr; 208(4):299-306. PubMed ID: 16565592
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?
De Ruysscher D; Van Meerbeeck J; Vandecasteele K; Oberije C; Pijls M; Dingemans AM; Reymen B; van Baardwijk A; Wanders R; Lammering G; Lambin P; De Neve W
Strahlenther Onkol; 2012 Jul; 188(7):564-7. PubMed ID: 22543884
[TBL] [Abstract][Full Text] [Related]
29. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
30. Acute radiation esophagitis caused by high-dose involved field radiotherapy with concurrent cisplatin and vinorelbine for stage III non-small cell lung cancer.
Kuroda Y; Sekine I; Sumi M; Sekii S; Takahashi K; Inaba K; Horinouchi H; Nokihara H; Yamamoto N; Kubota K; Murakami N; Morota M; Mayahara H; Ito Y; Tamura T; Nemoto K; Itami J
Technol Cancer Res Treat; 2013 Aug; 12(4):333-9. PubMed ID: 23369154
[TBL] [Abstract][Full Text] [Related]
31. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
32. Model development of dose and volume predictors for esophagitis induced during chemoradiotherapy for lung cancer as a step towards radiobiological treatment planning.
He R; Duggar WN; Yang CC; Vijayakumar S
BMC Pulm Med; 2023 Oct; 23(1):379. PubMed ID: 37814254
[TBL] [Abstract][Full Text] [Related]
33. Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy.
Wijsman R; Dankers F; Troost EG; Hoffmann AL; van der Heijden EH; de Geus-Oei LF; Bussink J
Radiother Oncol; 2015 Oct; 117(1):49-54. PubMed ID: 26341608
[TBL] [Abstract][Full Text] [Related]
34. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
Patel AB; Edelman MJ; Kwok Y; Krasna MJ; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1106-12. PubMed ID: 15519781
[TBL] [Abstract][Full Text] [Related]
35. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.
Kwint M; Uyterlinde W; Nijkamp J; Chen C; de Bois J; Sonke JJ; van den Heuvel M; Knegjens J; van Herk M; Belderbos J
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e223-8. PubMed ID: 22560551
[TBL] [Abstract][Full Text] [Related]
36. Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients.
Huang EX; Bradley JD; El Naqa I; Hope AJ; Lindsay PE; Bosch WR; Matthews JW; Sause WT; Graham MV; Deasy JO
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1674-9. PubMed ID: 21658856
[TBL] [Abstract][Full Text] [Related]
37. An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy.
Ma L; Qiu B; Li Q; Chen L; Wang B; Hu Y; Liu M; Zhang L; Huang Y; Deng X; Xia Y; Lin M; Liu H
Radiat Oncol; 2018 Jul; 13(1):130. PubMed ID: 30016978
[TBL] [Abstract][Full Text] [Related]
38. (18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.
Niedzielski JS; Yang J; Liao Z; Gomez DR; Stingo F; Mohan R; Martel MK; Briere TM; Court LE
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):670-8. PubMed ID: 27681764
[TBL] [Abstract][Full Text] [Related]
39. [Multi-factor analysis of radiation-induced esophagitis in three-dimensional conformal radiotherapy for non-small cell lung cancer].
Gu T; Hua HX; Fu ZZ; Zhang SH; Cao XY; Zhang QH; Yang S
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):868-71. PubMed ID: 22335956
[TBL] [Abstract][Full Text] [Related]
40. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
